Long-Term Effects of COVID-19 on Women’s Reproductive Health and Its Association with Autoimmune Diseases, Including Multiple Sclerosis
Journal of Clinical Medicine · 29.04.2025 · 14 (9) · 3057
DOI: 10.3390/jcm14093057 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.04.2025. Verfasst von Efthalia Moustakli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Genetics, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Concern over COVID-19’s long-term influence on women’s reproductive health is growing, with emerging research suggesting potential links to ovarian dysfunction, menstrual irregularities, fertility challenges, and adverse pregnancy outcomes. Post-viral immune dysregulation is linked to both the development and exacerbation of autoimmune diseases, including multiple sclerosis (MS). Long COVID has been associated with immunological dysfunction, hormonal imbalances, and chronic inflammation, all of which may worsen autoimmune disorders and reproductive health issues. Long COVID is characterized by symptoms persisting for weeks or months beyond the acute infection phase. There are indications that prolonged COVID may contribute to autoimmune disease development through mechanisms such as immune hyperactivation, molecular mimicry, and dysregulated cytokine responses. Although this research field is still emerging, growing evidence suggests that SARS-CoV-2 infection may have lasting effects on women’s health, highlighting the need for further studies into its underlying mechanisms and long-term clinical outcomes. This review compiles recent findings on the long-term impact of COVID-19 on women’s reproductive health and its potential association with autoimmune disorders, particularly MS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Medical Genetics, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
- Third Department of Obstetrics and Gynecology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
- Department of Biological Applications & Technology, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
- Department of Urology, School of Medicine, University of Ioannina, 45110 Ioannina, Greece.
- Department of Obstetrics and Gynecology, Medical School, University of Ioannina, 45110 Ioannina, Greece.
- First Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
ORCID-Profile: Theologos M Michaelidis, Anastasios Potiris, Chrysi Christodoulaki, Athanasios Zachariou, Konstantinos Zikopoulos, Athanasios Zikopoulos
Zitieren
APA
Moustakli, E., Stavros, S., Michaelidis, T. M., Potiris, A., Christodoulaki, C., Zachariou, A., Drakakis, P., Zikopoulos, K., Domali, E., & Zikopoulos, A. (2025). Long-Term Effects of COVID-19 on Women’s Reproductive Health and Its Association with Autoimmune Diseases, Including Multiple Sclerosis. Journal of Clinical Medicine, 14(9), 3057. https://doi.org/10.3390/jcm14093057
Vancouver
Moustakli E, Stavros S, Michaelidis TM, Potiris A, Christodoulaki C, Zachariou A, et al. Long-Term Effects of COVID-19 on Women’s Reproductive Health and Its Association with Autoimmune Diseases, Including Multiple Sclerosis. Journal of Clinical Medicine. 2025;14(9):3057. doi:10.3390/jcm14093057
BibTeX
@article{Moustakli2025,
author = {Moustakli, Efthalia and Stavros, Sofoklis and Michaelidis, Theologos M and Potiris, Anastasios and Christodoulaki, Chrysi and Zachariou, Athanasios and Drakakis, Peter and Zikopoulos, Konstantinos and Domali, Ekaterini and Zikopoulos, Athanasios},
title = {Long-Term Effects of COVID-19 on Women’s Reproductive Health and Its Association with Autoimmune Diseases, Including Multiple Sclerosis},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {9},
pages = {3057},
doi = {10.3390/jcm14093057}
}
EUVIMED